Patterns of craving and pharmacokinetics in long-term opiate addicts in methadone maintenance therapy

Addiction Research and Theory

Volumn 3, Issue 4, 1996, Pages 285-295

  De Vos, J W ^a,d   Van Wilgenburg, H ^a   Van Den Brink, W ^b   Kaplan, C D ^c   De Vries, M W ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b AMSTERDAM INSTITUTE FOR ADDICTION RESEARCH   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Craving; Dose response relationship; Drug addiction; ESM; Experience sampling method; GHQ 28; Methadone; Methadone maintenance therapy; MMT; PKPD analysis; SCL 90

Indexed keywords

EID: 2842551646     PISSN: 16066359     EISSN: None     Source Type: Journal    
DOI: 10.3109/16066359609005243     Document Type: Article

References (41)

1. Baselt, R. C and Casarett, L. J. (1972) Urinary excretion of methadone in man. Clin. Pharmacol. Ther., 13, 64-70.
2. Ball, J. C. and Ross, A. (1991) The effectiveness of methadone maintenance treatment. Springer-Verlag, New York.
3. Bell, J., Seres, V., Bowron, P., Lewis, J. and Batey, R. (1988) The use of serum methadone levels in patients receiving methadone maintenance. Clin. Pharmacol. Ther., 43, 623-629.
4. Bell, J., Bowron, P., Lewis, J. and Batey, R. (1990) Serum levels of methadone in maintenance clients who persist in illicit drug use. Br. J. Addict., 85, 1599-1602.
5. Bellward, G. D., Warren, P. M., Howard, W., Axelson, J. E. and Abbott, F. S. (1977) Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses. Clin. Pharmacol. Ther., 22, 92-99.
6. Caplehorn, J. R., Bell, J., Kleinbaum, D. G. and Gebski, V. J. (1993) Methadone dose and heroin use during maintenance treatment. Addiction, 88, 119-124.
7. Caplehorn, J. R., Dalton, M. S., Cluff, M. C. and Petrenas, A. M. (1994) Retention in methadone maintenance and heroin addict's risk of death. Addiction, 89, 203-209.
8. Childress, A. R., McLellan, A. T. and O'Brien, C. P. (1986) Conditioned responses in a methadone population. A comparison of laboratory, clinic, and natural settings. J. Subst. Abuse Treat., 3, 173-179.
9. Csikszentmihaly, M. and Larson, R. (1987) Validity and reliability of the experience-sampling method. J. Nerv. Ment. Dis., 175, 526-536.
10. De Vos, J. W., Geerlings, P. J., van den Brink, W., Ufkes, J. G. R. and van Wilgenburg, H. (1995) Pharmacokinetics of methadone and its primary metabolite in twenty opiate addicts. Eur. J. Clin. Pharmacol., 48, 361-366.
11. De Vos, J. W. and van den Brink, W. Opiate craving and presence of psychopathology. Eur. Addict. Res., Submitted.
12. De Vries, M. W. (1987) Investigating mental disorders in their natural settings. J. Nerv. Ment. Disease, 175, 509-513.
13. Dole, V. P. and Nyswander, M. E. (1965) A medical treatment for diacetylmorphine (heroin) addiction. JAMA, 193, 646-650.
14. Dole, V. P. (1994) Conversation with Vincent Dole. Addiction, 89, 23-29.
15. Goldstein, A., Hansteen, R. W. and Horns, W. H. (1975) Control of methadone dosage by patients. JAMA, 234, 734-737.
16. Handal, P. J. and Lander, J. J. (1976) Methadone treatment: program evaluation and dose response relationships. Int. J. Addict., 11, 363-375.
17. Hargreaves, W. A. (1983) Methadone dosage and duration for maintenance treatment. In, Research on the treatment of narcotic addiction. Ed. J. R. Cooper. DHHS Publication no. (ADM) 97-1281. Washington, DC.
18. Holmstrand, J., Ånggård, E., Gunne, L. M. (1978) Methadone maintenance: plasma levels and therapeutic outcome. Clin. Pharmacol. Ther., 23, 176-180.
19. Horns, W. H., Rado, M. and Goldstein, A. (1975) Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride. Clin. Pharmacol. Ther., 17, 636-649.
20. Hubbard, R. L., Marsden, M. E., Fachas, J. V., Harwood, H. J., Cavanaugh, E. R. and Ginzburg, H. M. (1989) Drug abuse treatment: a national study of effectiveness. Chapel Hill: University of North Carolina Press.
21. Kaplan, C. D. (1992) Drug craving and drug use in the daily life of heroin addicts. In: The experience of psychopathology: Investigating mental disorders in their natural settings. Ed. MW de Vries. Cambridge University Press, Cambridge.
22. Kell, M. J. (1994) Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting. J. Addict. Dis., 13, 5-26.
23. Kreek, M. J., Bencsath, F. A. and Field, F. H. (1980) Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: quantitation by direct probe chemical ionization mass spectrometry. Biomed. Mass. Spectrom., 7, 385-395.
24. Ling, W., Rawson, R. A. and Compton, M. A. (1994) Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. J. Psychoact. Drugs, 26, 119-128.
25. Loimer, N. and Schmid, R. (1992) The use of plasma levels to optimize methadone maintenance treatment. Drug Alcohol Depend, 30, 241-246.
26. Maddux, J. F., Esquivel, M., Vogtsberger, K. N. and Desmond, D. P. (1991) Methadone dose and urine morphine. J. Subst. Abuse Treat., 8, 195-201.
27. Maremmani, I., Zolesi, O., Agneci, T. and Castrogiovanni, P. (1993) Methadone doses and psychopathological symptoms during methadone maintenance. J. Psychoact. Drugs, 25, 253-256.
28. Maremmani, I., Nardini, R., Zolesi, O. and Castrogiovanni, P. (1994) Methadone dosages and therapeutic compliance during a methadone maintenance program. Drug Alcohol Depend, 34, 163-166.
29. Nilsson, M. I., Widerlöv, E., Meresaar, U. and Ånggård, E. (1982) Effect of urinary pH on the disposition of methadone in man. Eur. J. Clin. Pharmacol., 22, 337-342.
30. Norusis, M. J. (1988) SPSS-PC plus base manual. Chicago. SPSS.
31. Novick, D. M., Kreek, M. J., Fanizza, A. M., Yancovitch, S. R., Gelb, A. M. and Stenger, R. J. (1981) Methadone disposition in patients with chronic liver disease. Clin. Pharmacol. Ther., 30, 353-362.
32. Parrino, M. W., Consensus Panel Chair (1993) State methadone treatment guidelines. Treatment Improvement Protocol (TIP) Series. DHHS Publication no. (SMA) 93-1991. Rockville, MD.
33. Powell, J., Bradley, B. and Gray, J. (1992) Classical conditioning and cognitive determinants of subjective craving for opiates: an investigation of their relative contributions. Brit. J. Addict., 87, 1133-1144.
34. Robinson, T. E. and Berridge, K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Reviews, 18, 247-291.
35. Roszell, D. K. and Calsyn, D. A. (1986) Methadone dosage: patient characteristics and clinical correlates. Int. J. Addict., 21, 1233-1246.
36. Simpson, D. D. and Sells, S. B. (1982) Effectiveness of treatment for drug abuse: An overview of the DARP research program. Advances in Alcohol and Substance Abuse, 2, 7-29.
37. Strain, E. C., Stitzer, M. L., Liebson, I. A. and Bigelow, G. E. (1993a) Dose-response effects of methadone in the treatment of opioid dependence. Ann. Intern. Med., 119, 23-27.
38. Strain, E. C., Stitzer, M. L., Liebson, I. A. and Bigelow, G. E. (1993b) Methadone dose and treatment outcome. Drug Alcohol Depend, 33, 105-117.
39. Tennant, F. S. Jr., Rawson, R. A., Cohen, A., Tarver, A. and Clabough, D. (1984) Methadone plasma levels and persistent drug abuse in high dose maintenance patients. NIDA Res. Monogr., 49, 262-268.
40. Treece, C. and Nicholson, B. (1980) DSM-III personality type and dose levels in methadone maintenance patients. J. Nerv. Ment. Dis., 168, 621-628.
41. Whitehead, C. C. (1974) Methadone pseudowithdrawal syndrome: paradigm for a psychopharmacological model of opiate addiction. Psychosom. Med., 36, 189-198.